Leadership duties shift within CDER

01/31/2012 | Pharmalot.com

Bob Temple is giving up his post as acting director of the Office of Drug Evaluation I at the FDA's Center for Drug Evaluation and Research and will be replaced by Ellis Unger, the office's deputy director. The change will allow Temple to devote more time to his duties as deputy director for clinical science, according to CDER Director Janet Woodcock.

View Full Article in:

Pharmalot.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD